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Introduction 
Renal ischemia reperfusion injury (IRI), which occurs 
during kidney transplantation, partial nephrectomy, and 
elective  urological  operations,  is  a  common  cause  of 
acute renal failure (ARF). Ischemia insult, during renal 
transplantation,  is  responsible  for  primary  graft 
dysfunction.
1 Reperfusion (re-establishing blood flow) 
of  ischemic  renal  tissue  is  highly  damaging  and 
initiates a series of cellular events that lead to necrotic 
and  apoptotic  cell  death.  Several  mechanisms 
contribute  to  the  pathophysiology  of  ischemia 
reperfusion  injury,  such  as  reactive  oxygen  species 
(ROS),  ATP  depletion  and  increased  neutrophil 
infiltration.
2  Therefore,  increased  generation  of 
inflammatory  cytokines  and  ROS  in  the  reperfusion 
phase is believed to play a pivotal role. The excessive 
production  of  reactive  oxygen  and  nitrogen  species 
(RNS)  after  reperfusion  results  in  the  expression  of 
genes  for  pro-inflammatory  mediators,  the  lipid 
peroxidation of the cellular membranes and oxidative 
DNA damage, with the subsequent generation of toxic 
metabolites causing apoptotic cell death.
3  
Lipid peroxidation is related to IR injury-induced tissue 
damage and malondialdehyde (MDA) is an indicator of 
the  rate  of  lipid  peroxidation.
4  Several  anti-
inflammatory  and  antioxidant  agents  have  been 
explored  to  be  effective  in  reducing  renal  ischemia-
reperfusion injury.
5, 6  
Erythropoietin  (EPO)  is  a  hypoxia-inducible 
hematopoietic  factor,  a  key  protein  in  red  blood  cell 
production,  which  is  predominantly  expressed  in  the 
kidney. EPO has multiple protective effects, including 
antioxidant,  anti-inflammatory,  angiogenic,  and  anti-
apoptotic  effects.
7  The  biological  effects  of 
erythropoietin are mediated by binding to its specific 
cell  surface  receptor  (EPOR),  and  the  presence  of 
functional  EPOR  in  renal  mesangial  and  tubular 
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Purpose: Renal ischemia reperfusion (IR) is an important cause of renal dysfunction. It 
contributes to the development of acute renal failure (ARF). The purpose of this study 
was to investigate the anti-inflammatory effect of erythropoietin (EPO) and melatonin 
(MEL), which are known anti-inflammatory and antioxidant agents, in IR-induced renal 
injury in rats. 
Methods: Male Wistar Albino rats were unilaterally nephrectomized and subjected to 45 
min of renal pedicle occlusion followed by 24 h reperfusion. MEL (10mg/kg, i.p) and 
EPO (5000U/kg, i.p) were administered prior to ischemia. After 24 h reperfusion, blood 
samples  were  collected  for  the  determination  of  total  antioxidant  capacity  (TAC), 
malondialdehyde (MDA) and serum creatinine levels. Also, renal samples were taken 
for  Immunohistochemical  evaluation  of  Bcl2  and  TNF-α  (tumor  necrosis  factor-α) 
expression.  
Results:  Ischemia  reperfusion  increased  creatinine,  TAC,  MDA  levels  and  TNF-α 
expression, also, IR decreased Bcl2 expression. Treatment with EPO or MEL decreased 
creatinine,  MDA  levels,  and  increased  TAC  level.  Also,  MEL  up-regulated  Bcl2 
expression and down-regulated TNF-α expression compared with EPO. 
Conclusion: Treatment with EPO and MEL had a curative effect on renal IR injury. 
These results may indicate that MEL protects against inflammation and apoptosis better 
than EPO in renal IR injury.  
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epithelial  cells  has  pointed  to  a  potential  role  for 
erythropoietin in the kidney.
8 One important effect of 
erythropoietin  is  the  reduction  in  apoptosis  and 
oxidative stress.
9 It is also revealed that renal EPO level 
lowered after renal ischemia reperfusion.
10 
 Melatonin  (N-acetyl-5-methoxytryptamine)  is  the 
major product of the pineal gland that functions as a 
regulator  of  sleep,  circadian  rhythm,  and  immune 
function.
11 Melatonin (MEL) and its metabolites have 
potent  antioxidant/anti-inflammatory  properties  and 
have been proved to be highly effective in a variety of 
disorders linked to inflammation and oxidative stress.
12 
MEL not only neutralizes RNS and ROS species, but 
also acts through stimulation of several anti-oxidative 
systems and stabilizing cell membranes.
13 It modulates 
the gene expression of several protective enzymes and 
reduces apoptosis and lipid peroxidation.
14  
Therefore, ROS and inflammation have been shown to 
contribute to the cellular damage induced by ischemia-
reperfusion.  The  aim  of  the  present  study  was  to 
examine the potential effects of EPO and MEL on renal 
IR injury. For this purpose, we measured the  plasma 
levels  of  MDA,  total  antioxidant  capacity  (TAC), 
creatinine  (Cr),  and  using  immunohistochemistry 
(IHC),  expression  of  anti-apoptotic  Bcl2  and 
inflammatory mediator TNF-α  were assessed in  renal 
sections  after  ischemia  reperfusion  (IR)  in  rats 
subjected to renal IR injury. 
 
Materials and Methods 
Animals  
 In this study, 40 male Wistar- Albino rats (weighing 
200  -  300g)  were  obtained  from  the  experimental 
animal  research  center,  Medical  Faculty,  Tabriz 
University, Iran. The animals were housed in a room 
temperature  (21±2  °C)  and  humidity  (60±5%) 
controlled  room  in  which  a  12-12  h  light-dark  cycle 
was maintained. They had free access to standard water 
and food. The study was approved by the University 
Ethics Committee. 
 
Surgery and Experimental protocol 
Rats  were  anaesthetized  with  75  mg/kg  ketamine 
hydrochloride  and  8  mg/kg  xylazine,  intraperitoneal 
injection. Right nephrectomy was performed and then, 
the left renal pedicle (artery and vein) was occluded by 
placing  a  microvascular  clamp  for  45  min  to  induce 
ischemia and then subjected to reperfusion for 24h. 
The  animals  were  divided  into  four  groups  of  10 
animals each (n=10). 
1.  The  sham  group  of  animals  underwent  only 
nephrectomy without occlusion. 
2.  IR group (ischemic control) 
3.  MEL + IR group  
4.  EPO + IR group  
MEL (10 mg/kg; i.p) or vehicle (1% alcohol in saline) 
was  administered  10  min  prior  to  ischemia.  MEL 
(Sigma,  St.  Louis,  MO,  USA)  was  dissolved  in 
absolute  ethanol  and  then  diluted  in  saline  to  give  a 
final  alcohol  concentration  of  1%  ethanol.  EPO 
(Neorecormon,  Roche,  Mannheim,  Germany)  was 
administered  as  a  5000  U/kg  single  dose, 
intraperitoneally 10 min before ischemia. 
 
Biochemical analysis 
The blood samples and left kidney tissues of the rats 
were obtained after 24 h reperfusion in each group for 
determination  of  plasma  levels  of  TAC,  MDA  and 
creatinine.  The  blood  samples  were  centrifuged  at 
approximately 4000g for 10 min at 4°C. The Cr level in 
the serum was determined to assess the renal function, 
using the Autoanalyser (Alcyon 300 USA).  
 
Malondialdehyde assessment 
Plasma  MDA  levels  were  measured  using  the 
thiobarbituric  acid  reactive  substances  (TBARS) 
method.
15  
 
Total antioxidant capacity assessment 
 Plasma  TAC  was  determined  using  Randox  total 
antioxidant status kit in which ABTS (2, 2-Azino-di [3-
ethylbenzthiazolin  sulphanatel])  is  incubated  with  a 
peroxidase  and  hydrogen  peroxide  to  produce  the 
radical  cation  ABTS
+.  This  has  a  stable  blue  green 
color, which is determined at 600 nm. Antioxidants in 
the  added  sample  cause  suppression  of  this  color 
production to a degree which is proportional to their 
concentration.
16 
 
Immunohistochemistry   
Tissue  samples  preserved  in  10%  buffered  formalin 
were dehydrated, embedded in paraffin and sectioned at 
5  μm.  Sections  were  mounted  on  slides  and 
deparaffinized  in  xylene  (3  ˟  10  min)  and  ethanol 
(100% ethanol, 2  ˟ 5 min; 96%, 5 min; 70%, 5 min), 
then boiled with 10 mM citrate buffer in the microwave 
for 10 min, cooled down in citrate buffer for 20 min 
and rinsed with deionized water and PBS (phosphate 
buffered  saline).  To  quench  the  endogenous  activity, 
sections were incubated for 30 min in 0.1% H2O2 in 
methanol. They  were  then washed  in  PBS for  5  min 
and  incubated  with  diluted  normal  rabbit  serum 
(Abcam,  Cambridge,  UK)  for  20  min.  After  blotting 
excess  serum,  the  sections  were  incubated  with  the 
primary antibody in the dilution of 1/2000 for TNF-α 
(rabbit polyclonal  to TNF-α,  Abcam), the  dilution  of 
1/100 for Bcl-2 (rabbit  polyclonal to Bcl-2,  Abcam). 
For negative control, slides were incubated with diluted 
normal  rabbit  serum  (Abcam)  for  1  hr  in  room 
temperature. After the sections were rinsed in PBS, a 
supersensitive  biotinylated  secondary  antibody  (Goat 
polyclonal  to  Rabbit  IgG  -  H&L  (HRP);  Vector 
Laboratories Inc., Burlingame, CA, USA) was applied 
for 30 min. Slides were then rinsed in PBS again and 
incubated  for  30  min  with  Vectastain  ABC  Reagent 
(Vector  Laboratories  Inc.),  washed  in  PBS  and 
incubated  in  peroxidase  substrate  solution  (Vektor 
DAB  Peroxide  Substrate;  Vector  Laboratories  Inc.)  
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until  desired  stain  intensity  develops.  Under 
microscope, a color reaction (brown) can be seen and 
the reaction can then be stopped with water. 
Immunohistochemical  staining  for  TNF-α  and  Bcl-2 
was  examined  using  light  microscopy  by  an 
investigator blinded with respect to the animal group at 
a magnification of ˟40. In each group, 8 representative 
kidney sections were investigated, 20 view fields were 
counted per kidney section. To assess tubular staining 
for TNF-α and Bcl-2 expression, the following scoring 
system  was  used:  grade  0:  no  expression;  grade  1: 
minimal expression, grade 2: mild expression; grade 3: 
moderate expression; grade 4: severe expression.
17 
 
Statistical analysis 
All the data are presented as mean ± standard deviation 
(M±SD).  Significance  testing  between  groups  was 
performed  using  one-way  analysis  of  variance 
(ANOVA)  with  SPSS  Version  19  and  multiple 
comparison  post  hoc  test  to  determine  significant 
differences between groups. A P-value of less than 0.05 
was considered statistically significant. 
 
Results 
The  effect  of  EPO  and  MEL  on  renal  ischemia 
reperfusion  injury  was  investigated  in  45  minute  of 
renal  ischemia  followed  by  24  hour  reperfusion. 
Biochemical  analysis  results  are  outlined  in  Table  1, 
and using immunohistochemistry (IHC), expression of 
anti-apoptotic Bcl2 and inflammatory mediator TNF-α 
were assessed in renal sections after IR. 
 
Table 1. Biochemical measurements after 24 h of reperfusion 
Groups  Sham group  IR group 
MEL+IR 
group 
EPO+IR 
group 
Cr (mg/dl)  0.74±0.13  1.32±0.88
a  1.14±0.20  0.93±0.21 
 MDA(nmol/ml)  2.19±0.69  2.64±1.35  2.01±0.61  2.46±0.55 
TAC (mmol/l)  0.78±0.08  0.87±0.23  1.15±0.25
b  1.28±0.21
b 
a Significantly increased when compared with sham group, P<0.05. 
b Significantly increased when compared with IR group, P<0.05. 
Cr, creatinine; MDA, malondialdehyde; TAC, total antioxidant capacity; 
EPO, erythropoietin; MEL, melatonin; IR, ischemia reperfusion. 
 
Effects of ischemia reperfusion  
Serum creatinine level was significantly higher in the 
animals from IR group compared with those from sham 
group (P<0.05). The levels of MDA and TAC in the IR 
group were higher than those in the sham group, but the 
difference was not statistically significant (P > 0.05). In 
the sham group, there was prominent augmentation of 
Bcl2  expression  and  absence  of  TNF-α  expression 
(Figure 1 a, b). Renal IR caused an absence of Bcl2 
expression  and  great  increase  in  TNF-α  expression 
compared with the sham group (Figure 1 c, d).  
 
Effects of melatonin on renal ischemia reperfusion  
MDA  and  serum  creatinine  levels  in  the  MEL  +  IR 
group  were  lower  than  those  in  IR  group,  but  the 
difference  was  not  statistically  significant  (P>0.05). 
The  TAC  level  in  the  MEL  +  IR  group  was 
significantly higher than that in the IR group (P=0.01).  
MEL administration resulted in severe increase of Bcl2 
expression and marked reduction of TNF-α expression 
compared with IR group (Figure 1 e, f). 
 
 
Figure 1. (a, b) Bcl2 and TNF-α expression in renal tubules of 
the  sham  group.  (c)  Expression  of  Bcl2  after  renal  IR.  The 
lesser degree of Bcl2 expression in tubular epithelial cells of IR 
group. Magnification × 40. (d) Expression of TNF-α after renal 
IR. Increased TNF-α expression in tubular epithelial cells of IR 
group.  Magnification  ×20.  (e)  Expression  of  Bcl2  after  MEL 
administration. Increased Bcl2 expression in tubular epithelial 
cells of MEL group compared to IR group. Magnification × 40. 
(f) Expression of TNF-α after MEL administration. Decreased 
TNF-α  expression  in  tubular  epithelial  cells  of  MEL  group 
compared to  IR  group.  Magnification ×40.  (g)  Expression  of 
Bcl2  after  EPO  administration.  Minimal  increased  Bcl2 
expression in tubular epithelial cells of EPO group compared to 
IR group. Magnification  × 40. (h)  Expression of TNF-α  after 
EPO  administration.  Lesser  decreased  TNF-α  expression  in 
tubular epithelial cells of EPO group compared to IR group. 
Magnification ×20.  
 
Effects  of  erythropoietin  on  renal  ischemia 
reperfusion  
 MDA  and  serum  creatinine  levels  in  the  EPO  +  IR 
group were lower than those in the IR group, but the 
difference  was  not  statistically  significant  (P  > 
0.05).The  TAC  level  in  the  EPO  +  IR  group  was 
significantly  higher  than  that  in  the  IR  group 
(P=0.000).  
EPO  administration  resulted  in  minimal  Bcl2 
expression and moderate TNF-α expression, nearly at 
the same level of IR group (Figure 1 g, h).  
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Discussion 
Renal  IR  is  a  common  result  of  clinical  procedures 
such as organ procurement, vascular surgery, or renal 
transplantation.  Furthermore,  renal  IR  injury  is  a 
leading cause of  ARF, which is  associated with  high 
mortality  rates.  ARF  is  characterized  by  increased 
vascular resistance in the kidney, a low rate of filtration 
through  the  glomeruli,  and  tubular  necrosis.  These 
deleterious  effects  have  been  attributed  to  ROS 
generation during renal reperfusion.
18 ROS contributes 
to lethal cell damage. IR injury has been attributed to 
ROS-mediated lipid peroxidation.
19  
We  found  that  renal  IR  insignificantly  increased  the 
plasma  level  of  TAC.  Increased  total  antioxidant 
capacity  indicates  a  cellular  defensive  response  to 
overproduction of ROS after renal IR. ROS generation 
within cells is countered by sophisticated extracellular 
and  intracellular  antioxidant  defense  systems.  These 
can  be  divided  into  enzymatic  and  non-enzymatic 
antioxidant  systems,  which  effectively  combine 
different  antioxidant  activities  such  as  those  that 
prevent  ROS  formation  and  distribution,  maintain 
antioxidant  enzyme  levels  and  activities,  scavenge 
ROS, and repair ROS –mediated cellular injury. 
20 
Our  results  demonstrated  that  EPO  and  MEL 
significantly increased the level of TAC. This effect of 
EPO  and  MEL  may  be  due  to  their  antioxidant 
properties. Consistent with our finding, Kurcer et al.
21 
found  that  MEL  ameliorated  the  functional  and 
structural alterations in renal IR rats, decreased the total 
oxidative stress and increased the TAC. On the other 
hand, Dimitrijevic et al.
22 demonstrated that increase in 
TAC  accompanied  increasing  durations  of  EPO 
treatment and higher levels of TAC were also verified 
in the group with the longest duration of EPO treatment 
in hemodialysis patients.  
Lipid peroxidation, as a free radical generating system, 
has been proposed to be closely related to IR induced 
tissue  injury,  and  MDA  is  a  good  indicator  of  the 
degree of lipid peroxidation. In the present experiment, 
the  level  of  MDA  is  increased  by  IR,  which  reflects 
increased lipid peroxidation due to increased oxidative 
stress.  Erythropoietin  decreased  the  level  of  MDA, 
which shows that it decreased the amount of oxidative 
stress and subsequently lipid peroxidation.  Consistent 
with our findings, Ates et al.
23 demonstrated that EPO 
decreased the level of MDA after right nephrectomy, 
clamping of the left renal pedicle, and reperfusion in 
rats. Our results show that melatonin causes a reduction 
in  MDA  production,  indicating  a  reduction  in  lipid 
peroxidation  and  cellular  damage.  This  protective 
effect of MEL may be in part by scavenging the very 
reactive ONOO
- and OH.
24  
IR injury of the kidney results in both glomerular and 
tubular  dysfunctions.
25  In  our  study,  IR  significantly 
increased  creatinine  level,  suggesting  an  impaired 
glomerular  function  which  was  greatly  reduced  after 
EPO  and  MEL  treatment.  It  is  shown  that  the 
administration of EPO before ischemia attenuated the 
deterioration in renal function as a result of IR injury.
23 
Also,  it  is  shown  that  the  administration  of  MEL 
retards deterioration of renal function and structure.
26 
In the present study, Immunohistochemical assessment 
showed  that  IR  caused  increase  in  pro-inflammatory 
cytokine such as TNF-α. It has been reported that renal 
IR causes synthesis of pro-inflammatory cytokines such 
as TNF-α, IL-1, and IL-6.
27,28 EPO treatment did not 
obviously  modify  the  TNF-α  expression  in  kidney 
tubules when compared with the IR group. Sølling et 
al.
29  reported  that  EPO  did  not  modify  the 
inflammatory  response  in  a  porcine  model  of 
endotoxemia.  MEL  severely  attenuated  the  TNF-α 
expression, this effect of MEL may be due to its anti-
inflammatory  properties.  Consistent  with  this  finding, 
kireev  et  al.
30  indicated  that  MEL  administration 
lowered the expression of TNF-α and IL-1β in hepatic 
ischemia/reperfusion. In our study, renal IR resulted in 
decreased  expression  of  Bcl2  protein  at  24h 
reperfusion,  indicating  that  down-regulation  of  Bcl2 
protein could contribute in apoptotic cell death in renal 
IR.  Previous  studies  conducted  in  similar  animal 
models  of  renal  IR  injury  have  shown  that  ischemia 
leads to an increase in the Bax/Bcl2 ratio suggesting 
that  the  fine  balance  between  the  activity  of  pro-
apoptotic and anti-apoptotic Bcl2 family members can 
determine cell survival and modulate the induction of 
apoptosis.
31 MEL severely increased Bcl2 expression in 
renal  tissue.  This  effect  of  MEL  may  be  due  to  its 
powerful  anti-apoptotic  properties.  Tunon  et  al.
32 
reported that some anti-apoptotic effects of MEL were 
related to a reduced expression of Bax and also to the 
diminished cytochrome C release to the cytosol, to the 
increased  expression  of  Bcl2  and  Bcl-xL,  and  to  the 
inhibition of caspase-9 activity in an animal model of 
fulminant hepatic failure. In the EPO group, the Bcl2 
expression  did  not  show  obvious  changes  in  kidney 
when  compared  with  IR  group.  Consistent  with  this 
finding,  Johnson  et  al.
33  showed  that  there  was  no 
apparent  effect  in  the  model  of  ischemia  ARF  on 
promotion of the anti-apoptotic proteins Bcl2 and Bcl-
xL by EPO and darbepoetin. 
 
Conclusion 
In  conclusion,  ROS  are  considered  to  be  principal 
components  involved  in  the  pathophysiological  tissue 
alterations  observed  during  renal  IR.  Antioxidant 
defense  systems  or  TAC  activities  prevent  ROS 
formation  and  scavenge  ROS.  The  administration  of 
EPO and MEL, which are potent anti-inflammatory and 
antioxidant agents, appears to have beneficial effects on 
IR-induced renal injury as indicated by higher levels of 
TAC activity, and lower degree of renal dysfunction. 
However,  MEL  pretreatment  exerted  more 
nephroprotective  effect  than  EPO  pretreatment.  As 
MEL administration resulted in severe increase of Bcl2 
expression and marked reduction of TNF-α expression 
compared  with  EPO  group,  MEL  was  probably 
effective  to  reverse  renal  IR  by  its  potent  anti- 
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inflammatory and anti-apoptotic effects. These results 
may indicate that MEL protects against inflammation 
and  apoptosis  better  than  EPO  in  renal  IR  injury. 
However, further investigations are required to explore 
that the combination treatment of EPO and MEL has a 
synergistic effect of protection against IR-induced renal 
injury. 
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